aap Posts EUR 8.4 Million (+5%) in Sales and an EBIT of EUR 46K in First Quarter of 2009

aap Implantate AG, a medical technology company listed on the Frankfurt stock exchange achieved in the first three months of the fiscal year 2009 sales growth of 5% to EUR 8.4 million (previous year: EUR 8.0 million) and an operating result of EUR 46K (previous year: EUR 0.7 million).

The aap group of companies earned EUR 0.8 million in EBITDA (previous year: EUR 1.5 million) in the first quarter of 2009. Group EBIT totalled EUR 46K (previous year: EUR 0.7 million) and EBT EUR -0.2 million (previous year: EUR 0.5 million). On total assets of EUR 68.2 million (Dec. 31, 2008: EUR 67.0 million) the equity ratio was 62%.

Without non-recurring income – an initial order in 2008 and selling of a product in 2009, aap increased sales revenue by 13% which was achieved mainly in the core areas Traumatology & Orthopaedics as well as cement and cementing technology. In addition, the non-core area Medical Aesthetics showed a pleasing development.

For the full year 2008 aap anticipates a recovery of the sales growth by launching new products, expanding and acquiring new OEM partners, which shall also make for a recovery of the operational result.